DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pharmaceutical fraud
Pharmaceutical fraud
Punishing Pharmaceutical Companies for Unlawful Promotion of Approved Drugs: Why the False Claims Act Is the Wrong Rx
Pharmaceutical Fraud: Off-Label Marketing of Drugs in The
Punishing Pharmaceutical Companies for Unlawful Promotion of Approved Drugs: Why the False Claims Act Is the Wrong Rx Vicki W
Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs and the Federal Taxpayer"
Can You Blow My Whistle?
The Moral Hazard Problem with Privatization of Public Enforcement: the Case of Pharmaceutical Fraud
Pharmaceutical Fraud: Off-Label Marketing of Drugs in the United States, 2009 – 2016
The Relationship Between Overall Utilization and Settlements Involving Off-Label Promotion of Prescription Drugs
Twenty-Seven Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2017
Short-Sighted Value of Inefficiency: Why We Should Mind the Gap in the Reimbursement of Outpatient Prescription Drugs
Punishing Health Care Fraud — Is the GSK Settlement Sufficient? Kevin Outterson, J.D., LL.M
Support Sanders Amendment to Curtail Pharmaceutical Fraud, Hold Violators Accountable
A Failure of Remedies: the Case of Big Pharma (An Essay)
Health Care Fraud and Abuse Control Program Report
Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015
Polluting Medical Judgment? False Assumptions in the Pursuit of False Claims Regarding Off-Label Prescribing
Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2011
Physician Conflicts of Interest in Court: Beyond the Independent Physician Litigation Heuristic Kate Greenwood
Top View
EXHIBIT B Case 1:03-Cv-10641-RWZ Document 111-2 Filed 08/30/12 Page 2 of 68
Health Care Fraud and Abuse Can Badly Hurt the Intended Beneficiaries of Government Health Care Programs and Drain Resources We Need to Help the Truly Deserving
Off-Label Marketing of Pharmaceutical Products in the Wake of United States V
Pharmaceutical Fraud and Abuse in the United States, 1996-2010
Food and Drug Law Journal
Monetary Incentives for Producing Counterfeit, Adulterated, and Misbranded Medicine: Case Studies and Examples
Defending Government Pharmaceutical Fraud Investigations: Assessing Strategic Options by Katherine A
Whistle-Blowers' Experiences in Fraud Litigation Against Pharmaceutical
PHA 6290 Pharmaceutical Fraud & Abuse
Pharmaceutical Industry Criminal and Civil Penalties: an Update
Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015
A Survey of State Mirror False Claims Acts to Prosecute Fraud and Abuse Surrounding the Medicaid Program Alexa Salcito
Complaint for Damages, Civil Penalties, and Other Relief Under the Qui Tam Provisions of the Federal Civil False Claims Act and Similar State Statutes
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: a Retrospective Analysis of Whistleblower Complaints